ES2176199T3 - Derivados de indol como agonistas de s-ht1. - Google Patents

Derivados de indol como agonistas de s-ht1.

Info

Publication number
ES2176199T3
ES2176199T3 ES93906214T ES93906214T ES2176199T3 ES 2176199 T3 ES2176199 T3 ES 2176199T3 ES 93906214 T ES93906214 T ES 93906214T ES 93906214 T ES93906214 T ES 93906214T ES 2176199 T3 ES2176199 T3 ES 2176199T3
Authority
ES
Spain
Prior art keywords
association
rent
ring
arilo
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93906214T
Other languages
English (en)
Spanish (es)
Inventor
John E Macor
Jolanta T Nowakowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Application granted granted Critical
Publication of ES2176199T3 publication Critical patent/ES2176199T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES93906214T 1992-03-05 1993-03-03 Derivados de indol como agonistas de s-ht1. Expired - Lifetime ES2176199T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84664092A 1992-03-05 1992-03-05

Publications (1)

Publication Number Publication Date
ES2176199T3 true ES2176199T3 (es) 2002-12-01

Family

ID=25298499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93906214T Expired - Lifetime ES2176199T3 (es) 1992-03-05 1993-03-03 Derivados de indol como agonistas de s-ht1.

Country Status (30)

Country Link
US (2) US5594014A (OSRAM)
EP (1) EP0629199B1 (OSRAM)
JP (1) JPH07121943B2 (OSRAM)
KR (1) KR0179073B1 (OSRAM)
CN (4) CN1032309C (OSRAM)
AT (1) ATE218566T1 (OSRAM)
AU (1) AU666716B2 (OSRAM)
BR (1) BR9306012A (OSRAM)
CA (1) CA2117643C (OSRAM)
CZ (1) CZ282652B6 (OSRAM)
DE (1) DE69331988T2 (OSRAM)
DK (1) DK0629199T3 (OSRAM)
EG (1) EG20416A (OSRAM)
ES (1) ES2176199T3 (OSRAM)
FI (1) FI930968A7 (OSRAM)
HU (1) HU219489B (OSRAM)
IL (1) IL104941A (OSRAM)
MX (1) MX9301197A (OSRAM)
MY (1) MY109298A (OSRAM)
NO (1) NO302617B1 (OSRAM)
NZ (1) NZ249755A (OSRAM)
PL (1) PL172388B1 (OSRAM)
PT (1) PT629199E (OSRAM)
RU (1) RU2124012C1 (OSRAM)
SK (1) SK281938B6 (OSRAM)
TW (1) TW288010B (OSRAM)
UA (1) UA39866C2 (OSRAM)
WO (1) WO1993018032A1 (OSRAM)
YU (1) YU14893A (OSRAM)
ZA (1) ZA931539B (OSRAM)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
RU2101283C1 (ru) 1992-04-07 1998-01-10 Пфайзер Инк. Производные индола или их фармацевтически приемлемые соли
ATE170836T1 (de) * 1993-08-31 1998-09-15 Pfizer 5-arylindolderivate
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
EA199800611A1 (ru) * 1995-12-29 1999-04-29 Берингер, Ингельхайм Фармасьютиклс, Инк. Производные фенилтиазола с противогерпетическими свойствами
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
MXPA03004623A (es) 2000-11-27 2003-09-05 Pfizer Prod Inc Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
CA2444036A1 (en) * 2001-04-20 2002-10-31 Yanfang Li Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
GB0317229D0 (en) * 2003-07-23 2003-08-27 Pfizer Ltd Improved process
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
AU2021215709A1 (en) * 2020-02-04 2022-09-01 Mindset Pharma Inc. 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
PL243119B1 (pl) * 2020-04-16 2023-06-26 Univ Jagiellonski Rozpuszczalne w wodzie modyfikowane pochodne aminokwasowe nadające się do leczenia chorób o podłożu neurologicznym oraz zaburzeń psychiatrycznych

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
SI21560B (sl) * 1990-06-07 2005-04-30 Astrazeneca Ab 3,5-disubstituirani indolni derivati kot "5-HT1-podobni" receptorski agonisti
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW263508B (OSRAM) * 1991-02-12 1995-11-21 Pfizer

Also Published As

Publication number Publication date
MX9301197A (es) 1993-09-01
NZ249755A (en) 1996-08-27
JPH07500353A (ja) 1995-01-12
HU219489B (hu) 2001-04-28
KR0179073B1 (ko) 1999-03-20
YU14893A (sh) 1996-05-20
DE69331988T2 (de) 2002-09-19
CZ212594A3 (en) 1995-06-14
CA2117643C (en) 2000-03-14
JPH07121943B2 (ja) 1995-12-25
CN1032309C (zh) 1996-07-17
ZA931539B (en) 1994-09-05
FI930968A0 (fi) 1993-03-04
NO943261L (no) 1994-09-02
IL104941A0 (en) 1993-07-08
HUT64061A (en) 1993-11-29
CN1082815C (zh) 2002-04-17
MY109298A (en) 1996-12-31
IL104941A (en) 1998-06-15
PL172388B1 (pl) 1997-09-30
RU94040914A (ru) 1996-08-10
PT629199E (pt) 2002-09-30
SK105294A3 (en) 1995-05-10
DE69331988D1 (de) 2002-07-11
DK0629199T3 (da) 2002-07-15
EP0629199A1 (en) 1994-12-21
RU2124012C1 (ru) 1998-12-27
CN1082044A (zh) 1994-02-16
SK281938B6 (sk) 2001-09-11
HU9300593D0 (en) 1993-05-28
CN1136566A (zh) 1996-11-27
ATE218566T1 (de) 2002-06-15
AU666716B2 (en) 1996-02-22
CZ282652B6 (cs) 1997-08-13
CA2117643A1 (en) 1993-09-16
WO1993018032A1 (en) 1993-09-16
CN1136565A (zh) 1996-11-27
TW288010B (OSRAM) 1996-10-11
CN1044909C (zh) 1999-09-01
US5717102A (en) 1998-02-10
KR950700291A (ko) 1995-01-16
AU3733093A (en) 1993-10-05
CN1136432A (zh) 1996-11-27
BR9306012A (pt) 1997-11-18
FI930968A7 (fi) 1993-09-06
NO302617B1 (no) 1998-03-30
EP0629199B1 (en) 2002-06-05
CN1044910C (zh) 1999-09-01
EG20416A (en) 1999-02-28
US5594014A (en) 1997-01-14
NO943261D0 (no) 1994-09-02
UA39866C2 (uk) 2001-07-16

Similar Documents

Publication Publication Date Title
ES2176199T3 (es) Derivados de indol como agonistas de s-ht1.
ES2143992T3 (es) Derivados de 5-(hetero- o carbociclilamino)-indol, su preparacion y uso como 5-ht1 agonistas.
ES2083569T3 (es) Nuevos derivados de ariletenileno y procedimiento para su preparacion.
SE8104782L (sv) Heterocykliska foreningar
NO20052469L (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
NO932701L (no) Benzamidderivater
CO4650033A1 (es) Derivados de lactama con actividad selectiva agonista y antagonista de receptores de serotonina 1 (5ht) y composiciones farmaceuticas que los contienen .
CO4440628A1 (es) Derivados de pirimidina condensados con un anillo heteroci- clico
ES2196806T3 (es) Derivados de fenilurea y de feniltiourea.
AR013184A1 (es) Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
AR241161A2 (es) "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida"
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
ES2156305T3 (es) Derivados de ariletenosulfonamida y composiciones de farmacos que los contienen.
ES2066808T3 (es) Derivados de quinoleina, su produccion y uso.
ES2166379T3 (es) 2-aminotetralinas sustituidas.
ES2042593T3 (es) Procedimiento para la obtencion de derivados de la benzhidriloxietil-piperazina.
CO4970752A1 (es) Nuevos derivados de isatin y composiciones farmaceuticas conteniendo tales isatines
ES2038766T3 (es) 4-aril-5-carbamoil-1,4-dihidropiridinas.
OA08728A (fr) Dérivés aromatiques, leur préparation et leur utilisation comme antimicrobiens.
ES8603902A1 (es) Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos
ES2124896T3 (es) Amidas del acido ciclohexancarboxilico sustituidas con n-(piperidinil-1-alquilo) como antagonistas de receptores t-ht1a.
DK226285D0 (da) Beta-lactamforbindelser, deres fremstilling og anvendelse som laegemidler eller vaekstfremmende midler til dyr samt mellemprodukter til fremstillingen
ES8802149A1 (es) Un procedimiento para la preparacion de derivados de piperazinilo 1,4-disustituidos
ES2037011T3 (es) Procedimiento para la preparacion de nuevos derivados de benzofuran-2-il-imidazol.